Maya Health (Maya PBC) operates a real-world data platform and product suite that includes a Companion App for individuals, a Measurement Based Care Platform for providers, and a Real World Data Platform for researchers. The company positions itself to bridge psychedelic research and real-world practice by enabling collaboration among providers, participants, researchers, and regulators. It plans to bring its platform to market in 2022 and to expand personnel, develop its technologies, add business integrations for practitioners, and integrate with blockchain initiatives to enhance security, privacy, and transparency. Financially, Maya announced $4.3 million in its first investment rounds, consisting of an $800,000 angel round and a $3.5 million seed round. The platform is intended to accelerate pre-clinical research, enhance safety, optimize outcomes, and help reduce the cost of psychedelic care. Maya frames its mission around scaling psychedelic healthcare safely and effectively as a public benefit corporation based in Denver.

Total raised

$4M

Funding rounds

2

Latest round

Seed

Latest activity

Dec 2021